$1.56
0.117.59%
At Close: -
$1.56
00.00%
After Hours: Aug 23, 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Lyell Immunopharma (LYEL) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestLyell Immunopharma (NASDAQ:LYEL) Stock Quotes, Forecast and News Summary
Lyell Immunopharma Stock (NASDAQ: LYEL) stock price, news, charts, stock research, profile.
| Open | $1.45 |
| Close | $1.56 |
| Volume / Avg. | 824.27K / 947.70K |
| Day Range | $1.43 - $1.62 |
| 52 Wk Range | 1.18 - 3.26 |
| Market Cap | $399.36M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 53 |
| Short Interest | 9.05% |
| Days to Cover | 26.25 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Lyell Immunopharma Inc
Sector
Health Care
Industry
Biotechnology
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candid...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Lyell Immunopharma (LYEL) stock?
You can purchase shares of Lyell Immunopharma (NASDAQ:LYEL) through any online brokerage.
Who are Lyell Immunopharma (LYEL) competitors?
Other companies in Lyell Immunopharma’s space includes: Voyager Therapeutics (NASDAQ:VYGR), Inozyme Pharma (NASDAQ:INZY), Korro Bio (NASDAQ:KRRO), Fate Therapeutics (NASDAQ:FATE) and Anika Therapeutics (NASDAQ:ANIK).
What is the forecast, or price target, for Lyell Immunopharma (LYEL) stock?
Lyell Immunopharma has a consensus price target of $4.00.
What is the current price for Lyell Immunopharma (LYEL)?
The stock price for Lyell Immunopharma (NASDAQ: LYEL) is $1.56 last updated August 23, 2024 at 4:00 PM EDT.
Does Lyell Immunopharma (LYEL) pay a dividend?
There are no upcoming dividends for Lyell Immunopharma.
When is Lyell Immunopharma (NASDAQ:LYEL) reporting earnings?
Lyell Immunopharma’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
Is Lyell Immunopharma (LYEL) going to split?
There is no upcoming split for Lyell Immunopharma.
What sector and industry does Lyell Immunopharma (LYEL) operate in?
Lyell Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.